483 Baxter Pharmaceutical Solutions May 2013

483 Baxter Pharmaceutical Solutions May 2013

Rebecca Dombrowski FDA, Andrew Idzior FDA, Jeffrey Meng FDA, Sarah Napier FDA, Cheng Yen FDA, Sarah Meng FDA$119.00 - Available Now

FDA investigators audited the Baxter Pharmaceutical Solutions - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 10 May 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 10 May 2013
  • Location: Bloomington, United States
  • FEI: 1000115571
Add To Cart